help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Published ahead of print on November 10, 2005, doi:10.1164/rccm.200509-1478OE

Am. J. Respir. Crit. Care Med., Volume 173, Number 1, January 2006, 7-15

A more recent version of this article appeared on January 1, 2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
200509-1478OEv1
173/1/7    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pack, A. I
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pack, A. I

Submitted on September 21, 2005
Accepted on November 9, 2005

Advances in Sleep-Disordered Breathing

Allan I Pack1*

1 Department of Medicine, Division of Sleep Medicine, Center for Sleep and Respiratory Neurobiology, University of Pennsylvania School of Medicine, Philadelphia, PA, United States

* To whom correspondence should be addressed. E-mail: pack{at}mail.med.upenn.edu.

Since the original clarification of the obstructive nature of OSA in 1965, much has been learned about the disorder. It is a condition with a high prevalence with obesity as a major risk factor. It aggregates in families, a relationship that is not simply explained by obesity. Pre-menopausal women are relatively protected from the disorder with OSA being uncommon in this group. Its prevalence in women rises after menopause. While OSA is a risk factor for excessive sleepiness, there is developing evidence that it is also a risk factor for hypertension, acute cardiovascular events and insulin resistance. The first line of therapy is nasal continuous positive airway pressure (CPAP). Data as to the efficacy of CPAP in severe OSA have come from randomized, placebo-controlled clinical trials with the end-points being sleepiness, quality of life and 24-hour ambulatory blood pressure. Data are currently less convincing for treatment outcomes in mild-to-moderate OSA, and new clinical trials to assess outcomes in this group are underway. Thus, even though this field only began towards the end of the first century of the American Thoracic Society, substantial progress has been made, and OSA has increasingly emerged as a major public health concern.
Key words: Obstructive sleep apnea, Obesity, Hypertension, Metabolic Syndrome, Sleep




This article has been cited by other articles:


Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
G.-S. Hwang, S.-T. Chen, T.-J. Chen, and S.-W. Wang
Effects of hypoxia on testosterone release in rat Leydig cells
Am J Physiol Endocrinol Metab, November 1, 2009; 297(5): E1039 - E1045.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
M. Younes
Role of respiratory control mechanisms in the pathogenesis of obstructive sleep disorders
J Appl Physiol, November 1, 2008; 105(5): 1389 - 1405.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
V. K. Somers, D. P. White, R. Amin, W. T. Abraham, F. Costa, A. Culebras, S. Daniels, J. S. Floras, C. E. Hunt, L. J. Olson, et al.
Sleep Apnea and Cardiovascular Disease: An American Heart Association/American College of Cardiology Foundation Scientific Statement From the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing In Collaboration With the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health)
Circulation, September 2, 2008; 118(10): 1080 - 1111.
[Full Text] [PDF]

Home page
 J Am Board Fam MedHome page
F. B. Willis, A. L. Isley, Y. E. Geda, A. Shaygan, L. Quarles IV, and P. A. Fredrickson
Resolution of Syncope With Treatment of Sleep Apnea
J Am Board Fam Med, September 1, 2008; 21(5): 466 - 468.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
V. K. Somers, D. P. White, R. Amin, W. T. Abraham, F. Costa, A. Culebras, S. Daniels, J. S. Floras, C. E. Hunt, L. J. Olson, et al.
Sleep Apnea and Cardiovascular Disease: An American Heart Association/American College of Cardiology Foundation Scientific Statement From the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing In Collaboration With the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health)
J. Am. Coll. Cardiol., August 19, 2008; 52(8): 686 - 717.
[Full Text] [PDF]

Home page
 ERRHome page
B. Buyse, J. Hedner, and the participants of working group 2
Sleep apnoea, hypertension and vascular disease: where are we now?
Eur. Respir. Rev., December 1, 2007; 16(106): 169 - 182.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
M. Moss
Clinical Year in Review II: Interstitial Lung Disease, Sepsis, Pulmonary Infections, and Sleep Medicine
Proceedings of the ATS, September 15, 2007; 4(6): 482 - 488.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
R. L. Horner and T. D. Bradley
Update in Sleep and Control of Ventilation 2006
Am. J. Respir. Crit. Care Med., March 1, 2007; 175(5): 426 - 431.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2005 American Thoracic Society 		  New Orleans Int'l Conf